The added value of the 90-day repeated dose oral toxicity test for industrial chemicals with a low (sub)acute toxicity profile in a high quality dataset

Regulatory Toxicology and Pharmacology

Volumn 69, Issue 3, 2014, Pages 320-332

  Taylor, Katy ^a   Andrew, David J ^b   Rego, Laura ^a  

^a BUAV   (United Kingdom)

^b Grimbald Crag Court   (United Kingdom)

Author keywords

3Rs; Alternatives; Chemicals legislation; REACH; Repeated dose; Sub acute; Sub chronic

Indexed keywords

INDUSTRIAL CHEMICAL; PESTICIDE;

ACUTE TOXICITY; ARTICLE; BIOLOGICAL ACTIVITY; DATA BASE; DEVELOPMENTAL TOXICITY; EYE IRRITATION; GENOTOXICITY; HUMAN; NEPHROTOXICITY; NONHUMAN; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REPEATED DRUG DOSE; REPRODUCTIVE TOXICITY; SKIN TOXICITY; TOXICITY TESTING; ANIMAL; ANIMAL TESTING ALTERNATIVE; FACTUAL DATABASE; FEMALE; INDUSTRY; MALE; ORAL DRUG ADMINISTRATION; PROCEDURES;

ANIMALIA;

ADMINISTRATION, ORAL; ANIMAL TESTING ALTERNATIVES; ANIMALS; DATABASES, FACTUAL; FEMALE; HUMANS; INDUSTRY; MALE; TOXICITY TESTS;

EID: 84904038335     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2014.04.008     Document Type: Article

References (23)

1. Bulgheroni A., et al. Estimation of acute oral toxicity using the No Observed Adverse Effect Level (NOAEL) from the 28day repeated dose toxicity studies in rats. Regul. Toxicol. Pharmacol. 2009, 53:16-19.
2. Chapman K., et al. The value of acute toxicity studies to support the clinical management of overdose and poisoning: a cross-discipline consensus. Regul. Toxicol. Pharmacol. 2010, 58:354-359.
3. Creton S., et al. Acute toxicity testing of chemicals - opportunities to avoid redundant testing and use alternative approaches. Crit. Rev. Toxicol. 2010, 40:50-83.
4. ECHA, 2011. Comments and contributions received from MSC participants following the UK proposal and analysis concerning 'Possibilities for waiving repeat dose studies for low-toxicity substances (ECHA/MSC-16/2011/002)'. ECHA/MSC-18/2011/001 (6 May 2011).
5. ECHA, 2013. 2 923 more chemicals registered by industry under REACH. ECHA/PR/13/23, Helsinki (03 June 2013).
6. Fleischer M. Testing costs and testing capacity according to the REACH requirements - results of a survey of independent and corporate GLP laboratories in the EU and Switzerland. J. Bus. Chem. 2007, 4:96-114.
7. Friedrich A., Olejniczak K. Evaluation of carcinogenicity studies of medicinal products for human use authorised via the European centralised procedure (1995-2009). Regul. Toxicol. Pharmacol. 2011, 60:225-248.
8. HSE, 2011. A Weight-of-Evidence Approach for Justifying the Waiving the 90-Day Repeat Dose Toxicity Test under REACH. ECHA/MSC-16/2011/002. Helsinki (19 January 2011).
9. Janer G., et al. A retrospective analysis of the two-generation study: what is the added value of the second generation?. Reprod. Toxicol. 2007, 24:97-102.
10. Klimisch H.J., et al. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul. Toxicol. Pharmacol. 1997, 25:1-5.
11. Lordo R.A., et al. Comparing and evaluating alternative (in vitro) tests on their ability to predict the Draize maximum average score. Toxicol. In Vitro 1999, 13:45-72.
12. OECD, 1995. Reproduction/Developmental Toxicity Screening Test, Test Guideline No. 421. OECD Guidelines for the Testing of Chemicals, OECD, Paris (adopted: 27 July 1995).
13. OECD, 1996. Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test, Test Guideline No. 422. OECD Guidelines for the Testing of Chemicals, OECD, Paris (adopted: 22 March 1996).
14. OECD, 1998. Repeated Dose 90-Day Oral Toxicity Study in Rodents, Test Guideline No. 408. OECD Guidelines for the Testing of Chemicals, OECD, Paris (adopted: 21 September 1998).
15. OECD, 2004. Skin Absorption. In Vitro Method, Test Guideline No. 428, OECD Guidelines for the Testing of Chemicals. OECD, Paris (adopted: 3 November 2004).
16. OECD, 2005. Guidance Document on the Validation and International Acceptance of New or Updated Test Methods for Hazard Assessment. OECD Series on Testing and Assessment Number 34, OECD, Paris (25 August 2005).
17. OECD, 2008. Repeated Dose 28-Day Oral Toxicity Study in Rodents, Test Guideline No. 407. OECD Guidelines for the Testing of Chemicals. OECD, Paris (adopted: 3 October 2008).
18. Ohno Y., et al. Interlaboratory validation of the in vitro eye irritation tests for cosmetic ingredients. 1: overview of the validation study and Draize scores for the evaluation of the tests. Toxicol. In Vitro 1999, 13:73-98.
19. Pedersen, F., et al., 2003. Assessment of additional testing needs under REACH - effects of (Q)SARs, risk based testing and voluntary industry initiatives. JRC Report EUR 20863.
20. Robinson S., et al. A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development. Regul. Toxicol. Pharmacol. 2008, 50:345-352.
21. Sistare F.D., et al. An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines. Toxicol. Pathol. 2011, 39:716-744.
22. van Breemen R.B., Li Y. Caco-2 cell permeability assays to measure drug absorption. Expert Opin. Drug Metab. Toxicol. 2005, 1:175-185.
23. Weil C.S., Scala R.A. Study of intra- and interlaboratory variability in the results of rabbit eye and skin irritation tests. Toxicol. Appl. Pharmacol. 1971, 19:276-360.